Cancer Care and Prevention

Cancer Care and Prevention

An immediate priority of the Botswana-Rutgers Partnership for Health is to address the country’s urgent cancer care and prevention needs. The cancer mortality rate in Botswana is close to 75 percent, and many patients present with advanced disease. There are minimal prevention and support services, long delays in cancer detection and diagnosis, deficiencies in the availability of cancer medications, unreliable data registries, and severe shortages in the specialty-trained workforce.

In August 2019, we partnered with the University of Botswana and Botswana’s Ministry of Health and Wellness to conduct a national workshop on cancer care and prevention. The workshop outcomes and recommendations were compiled in this report.

By establishing a national, comprehensive cancer care and prevention program, Botswana can save lives, prevent disease, and create a model for implementation in other African nations and developing countries around the world.

As part of our work to build this program together with Botswana, the following projects are underway:

National Cancer Needs Assessment
Breast Cancer Research
Cancer Pathology Working Group
Global Oncology Fellowships

 

National Cancer Needs Assessment

The Botswana Comprehensive Cancer Care and Prevention Needs Assessment is an evaluation of the current health system and services available for cancer across the nation’s four hospitals that are referred to as “cancer centers.” These sites, which either currently provide or are planning to provide some level of oncologic care, are Princess Marina Hospital in Botswana’s capital city of Gaborone, Letsholathebe II Memorial Hospital in Maun, Nyangabgwe Referral Hospital in Francistown, and Sekgoma Memorial Hospital in Serowe.

This evaluation encompasses not only health facilities but also perspectives from health care providers, cancer patients and survivors, caregivers, members of the public, and local nongovernmental organizations that support cancer care and prevention programs. The evaluation was completed in April 2021 and included site visits, focus groups, and questionnaires; data analysis is underway.

The needs assessment will provide key insights into awareness about cancer and its prevention, disparities in access to cancer-related services, and the difficulties of care based on different locations and types of facilities in Botswana. With support from the Bristol Myers Squibb Foundation, the national cancer needs assessment also includes an assessment of cancer awareness at a population level to inform approaches for broader health campaigns throughout the country.

 

Breast Cancer Research

Breast cancer is a leading cause of cancer-related deaths for women in Botswana. A lack of screening and early detection, long delays in diagnosis, and limited treatment options mean that many women present with breast cancer at advanced stages, at which point recovery is far less likely.

There is a dire need to improve timely access to breast cancer care in Botswana. Our aim is to identify and address crucial deficiencies in information and support.

Our current project, “Improving Timely Access to Care for Women with Advanced Stage Breast Cancer in Botswana,” is funded by UICC’s (Union for International Cancer Control) SPARC MBC Challenge. Through qualitative research methods, such as focus group discussions with breast cancer patients and caregivers, we are uncovering gaps in breast cancer care at the patient level, clinician level, and health system level. We also are working to understand knowledge gaps in breast cancer care and prevention among primary care practitioners. Ultimately, to improve the care received by breast cancer patients with advanced disease, we will train and implement a system of patient navigators to assist and support patients through their treatment journey.

Learn more about this study.

 

Cancer Pathology Working Group

Group Pathology and laboratory medicine are critical to enabling accurate and early diagnoses of cancer, which in turn leads to improved chances of treatment and survival. However, these areas of Botswana’s health system require significant capacity building to fast-track cancer diagnoses, which currently can take months. The 28-member Botswana-Rutgers Cancer Pathology Working Group was launched in September 2020 to harness a collective commitment across Rutgers, Botswana’s Ministry of Health and Wellness, and the University of Botswana to improve pathology and laboratory medicine services for cancer throughout Botswana’s health system.

The group is currently involved in creating a digital collection of pathology cases for training purposes. Working in collaboration with the University of Botswana’s Department of Pathology, the Rutgers Cancer Institute’s biomedical informatics team is launching digital imaging capabilities for pathology slides. This will allow for a diverse spectrum of cancer biospecimens to be included as a teaching resource within a digital quiz bank. The digital imaging capabilities and quiz bank will allow for knowledge exchange between trainees at both institutions.

 

Global Oncology Fellowships

Since 2018, the global oncology fellowship program has provided Rutgers hematology/oncology fellows with a global oncology experience and has contributed to improving cancer care and prevention in Botswana. Rutgers Global Health Institute co-developed the fellowship program through partnerships with Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, the University of Botswana, and Princess Marina Hospital in Gaborone, Botswana.

Each year, two fellows participate in a yearlong program that includes a one-month research elective in Botswana. They gain exposure to the realities of cancer care in the country; provide mentorship to junior medical officers, residents, and hospital staff; and conduct research. Projects have included gathering and analyzing data on chemotherapy utilization and stockouts, developing cancer care guidelines, and creating oncology staff protocols.